Principal Financial Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,064
| Closed | -$18.5K | – | 2376 |
|
|
2024
Q1 | $18.5K | Sell |
1,064
-268
| -20% | -$4.65K | ﹤0.01% | 2413 |
|
|
2023
Q4 | $17.1K | Sell |
1,332
-87
| -6% | -$1.12K | ﹤0.01% | 2390 |
|
|
2023
Q3 | $52.5K | Buy |
1,419
+216
| +18% | +$7.99K | ﹤0.01% | 2345 |
|
|
2023
Q2 | $48.4K | Buy |
1,203
+133
| +12% | +$5.35K | ﹤0.01% | 2361 |
|
|
2023
Q1 | $77.6K | Buy |
1,070
+131
| +14% | +$9.5K | ﹤0.01% | 2331 |
|
|
2022
Q4 | $77K | Buy |
939
+123
| +15% | +$10.1K | ﹤0.01% | 2336 |
|
|
2022
Q3 | $77K | Buy |
816
+175
| +27% | +$16.5K | ﹤0.01% | 2373 |
|
|
2022
Q2 | $124K | Buy |
+641
| New | +$124K | ﹤0.01% | 2367 |
|
|
2022
Q1 | – | Sell |
-406
| Closed | -$160K | – | 2544 |
|
|
2021
Q4 | $160K | Sell |
406
-252
| -38% | -$99.3K | ﹤0.01% | 2396 |
|
|
2021
Q3 | $294K | Sell |
658
-107
| -14% | -$47.8K | ﹤0.01% | 2311 |
|
|
2021
Q2 | $297K | Sell |
765
-470
| -38% | -$182K | ﹤0.01% | 2357 |
|
|
2021
Q1 | $443K | Buy |
1,235
+6
| +0.5% | +$2.15K | ﹤0.01% | 2185 |
|
|
2020
Q4 | $603K | Buy |
1,229
+788
| +179% | +$387K | ﹤0.01% | 2069 |
|
|
2020
Q3 | $143K | Sell |
441
-21
| -5% | -$6.81K | ﹤0.01% | 2241 |
|
|
2020
Q2 | $168K | Buy |
+462
| New | +$168K | ﹤0.01% | 2209 |
|
|
2019
Q2 | – | Sell |
-503
| Closed | -$501K | – | 2230 |
|
|
2019
Q1 | $501K | Buy |
503
+243
| +93% | +$242K | ﹤0.01% | 1937 |
|
|
2018
Q4 | $226K | Sell |
260
-291
| -53% | -$253K | ﹤0.01% | 2100 |
|
|
2018
Q3 | $570K | Buy |
551
+80
| +17% | +$82.8K | ﹤0.01% | 1941 |
|
|
2018
Q2 | $433K | Buy |
471
+251
| +114% | +$231K | ﹤0.01% | 1991 |
|
|
2018
Q1 | $214K | Buy |
+220
| New | +$214K | ﹤0.01% | 2093 |
|